跳至主要内容
临床试验/NCT02276859
NCT02276859已完成4 期

The Optimal Type of Bolus Following a High-protein Meal in Type 1 Diabetic Children Treated With Insulin Pumps

Medical University of Warsaw1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2014年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
70
试验地点
1
主要终点
Postprandial glycemia

研究概览

简要总结

Patients receive a standardized high-protein test meal at breakfast time. Insulin is given as bolus (normal or dual-wave (normal plus square) and basal rate using an insulin pump. The 3h post-meal glucose excursions will be recorded by self-blood glucose measurements (SMBG) (every 1 hour) and continuous glucose monitoring system (CGMS). The intervention is taking part under in-patient clinical conditions.

详细描述

The dual-wave bolus delivers an immediate normal pre-meal insulin bolus followed by square-wave bolus that is evenly delivered over several hours as programmed by the patient. The aim of this study is to compare post-prandial glycaemic excursions following a high-protein meal after administration of insulin by normal vs dual-wave bolus. During this prospective, cross-over, repeated measures study, pediatric patients with type 1 diabetes, treated with insulin pump therapy will be evaluated using the self-blood glucose measurements following standardized high-protein meal and two types of boluses (normal or dual-wave). The required insulin dose will be calculated based on patient's insulin-exchange ratio. A high-protein meal will be given on two subsequent breakfasts and comparisons will be made between normal and dual-wave insulin bolus delivery. Prolonged post-prandial glycaemic excursions will be identified using the CGMS.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
10 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • duration of type 1 diabetes longer than 12 months
  • insulin pump therapy longer than 3 months
  • written informed consent by patients and parents
  • patients must be willing to wear a glucose sensor for two days
  • insulin requirement more than 0,5 units/kg/day

排除标准

  • concomitant dietary restrictions (e.g. celiac disease or food allergy)
  • diabetes related complications (e.g. nephropathy)
  • any disease judged by the investigator to affect the trial
  • withdrawal of consent to participate in the study

研究组 & 干预措施

Normal/ Dual-wave

Experimental

On the first study day, pre-breakfast insulin was given as a normal bolus 15 minutes before a standardized high-protein meal. On the second day, pre-breakfast insulin was given as a dual-wave bolus before the same high-protein meal.

The carbo-insulin and fat-protein-insulin ratio on both study days were identical to the patient's ratio when entering trial.

Kind of study bolus insulin will be a rapid-acting insulin analog same as previously used by the participant (before entering the trial) - insulin aspart, insulin lispro or insulin glulisine

干预措施: insulin lispro (Drug)

Normal/ Dual-wave

Experimental

On the first study day, pre-breakfast insulin was given as a normal bolus 15 minutes before a standardized high-protein meal. On the second day, pre-breakfast insulin was given as a dual-wave bolus before the same high-protein meal.

The carbo-insulin and fat-protein-insulin ratio on both study days were identical to the patient's ratio when entering trial.

Kind of study bolus insulin will be a rapid-acting insulin analog same as previously used by the participant (before entering the trial) - insulin aspart, insulin lispro or insulin glulisine

干预措施: insulin aspart (Drug)

Normal/ Dual-wave

Experimental

On the first study day, pre-breakfast insulin was given as a normal bolus 15 minutes before a standardized high-protein meal. On the second day, pre-breakfast insulin was given as a dual-wave bolus before the same high-protein meal.

The carbo-insulin and fat-protein-insulin ratio on both study days were identical to the patient's ratio when entering trial.

Kind of study bolus insulin will be a rapid-acting insulin analog same as previously used by the participant (before entering the trial) - insulin aspart, insulin lispro or insulin glulisine

干预措施: insulin glulisine (Drug)

Dual-wave/Normal

Experimental

On the first study day, pre-breakfast insulin was given as a dual-wave bolus 15 minutes before a standardized high-protein meal. On the second day, pre-breakfast insulin was given as a normal bolus before the same high-protein meal.

The carbo-insulin and fat-protein-insulin ratio on both study days were identical to the patient's ratio when entering trial.

Kind of study bolus insulin will be a rapid-acting insulin analog same as previously used by the participant (before entering the trial) - insulin aspart, insulin lispro or insulin glulisine

干预措施: insulin aspart (Drug)

Dual-wave/Normal

Experimental

On the first study day, pre-breakfast insulin was given as a dual-wave bolus 15 minutes before a standardized high-protein meal. On the second day, pre-breakfast insulin was given as a normal bolus before the same high-protein meal.

The carbo-insulin and fat-protein-insulin ratio on both study days were identical to the patient's ratio when entering trial.

Kind of study bolus insulin will be a rapid-acting insulin analog same as previously used by the participant (before entering the trial) - insulin aspart, insulin lispro or insulin glulisine

干预措施: insulin lispro (Drug)

Dual-wave/Normal

Experimental

On the first study day, pre-breakfast insulin was given as a dual-wave bolus 15 minutes before a standardized high-protein meal. On the second day, pre-breakfast insulin was given as a normal bolus before the same high-protein meal.

The carbo-insulin and fat-protein-insulin ratio on both study days were identical to the patient's ratio when entering trial.

Kind of study bolus insulin will be a rapid-acting insulin analog same as previously used by the participant (before entering the trial) - insulin aspart, insulin lispro or insulin glulisine

干预措施: insulin glulisine (Drug)

结局指标

主要结局

Postprandial glycemia

时间窗: 180 minutes after the meal

Post-prandial blood glucose excursions measured by self monitoring of blood glucose

次要结局

  • Hypoglycemia episodes(3-hour study period)
  • Glucose Area Under the Curve (AUC)(3-hour study period)
  • Mean amplitude of glycemic excursion(3-hour study period)

研究者

发起方
Medical University of Warsaw
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验